Cost-Effectiveness of One-time Universal Testing for Hepatitis D Among Adults With Chronic Hepatitis B in the United States
One-time HDV testing for all HBsAg-positive adults and treatment of chronic HDV infection with PEG-IFN is potentially cost-effective in the US.
Authors
- Mehlika Toy (ORCID: https://orcid.org/0000-0001-7848-4816)
- Eyasu H. Teshale (ORCID: https://orcid.org/0000-0001-5244-8251)
- David W. Hutton (ORCID: https://orcid.org/0000-0001-9677-1632)
- Joshua A. Salomon (ORCID: https://orcid.org/0000-0003-3929-5515)
- W. Thompson (ORCID: https://orcid.org/0000-0001-8293-9641)
- Thi T. Hang Pham (ORCID: https://orcid.org/0000-0002-2480-4586)
- Samuel So (ORCID: https://orcid.org/0000-0003-3108-086X)
Institutions
- Centers for Disease Control and Prevention (US)
- University of Michigan (US)
- Stanford Health Care (US)
- Center for Policy Analysis (US)
- Erasmus University Rotterdam (NL)
- Stanford University (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1093/cid/ciaf181
- Citations
- 6
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.13
Funders
- Centers for Disease Control and Prevention